[Further results of new therapy of Parkinsonian syndromes; therapeutic action of 3-phenyl-3-b-diethylamino-ethyl-2-6-dioxy-piperidine hydrochloride administered alone and with reserpine and ritalin].
D008774:Methylphenidate / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000628:therapy*; D020734:Parkinsonian Disorders; D010880:Piperidines; D012110:Reserpine / Q000627:therapeutic use*; D012492:Salts
D010276:Parasympatholytics; D010880:Piperidines; D012492:Salts; D008774:Methylphenidate; C032727:piperidine; D012110:Reserpine
METHYLPHENIDYLACETATE/therapeutic use; PARALYSIS AGITANS/therapy; PARASYMPATHOLYTICS/therapeutic use; RESERPINE/therapeutic use
Ulteriori risultati di nuove terapie nelle sindromi Parkinsoniane; attività terapeutiche del 3-fenil-3-b-dietilamino-etil-2-6-diossi-piperidin-cloridrato somministrato isolatamente e in associazione con reserpina e ritalin.